What Batch Documentation Should Accompany a Tesamorelin Vial
A reference guide to the batch documentation that should accompany a tesamorelin vial, including COAs, lot numbers, and how to read them.
Reviewed by Yuki Tanaka, PhD, molecular biologist ·
Yuki Tanaka, PhD is a molecular biologist with a doctorate from Osaka University and postdoctoral training at Stanford School of Medicine, specializing in growth hormone axis biology, GHRH receptor signaling, and synthetic peptide analog mechanisms.
What batch documentation should accompany a tesamorelin vial comes down to a short list of records that let a buyer or lab trace a specific lot back to its manufacturing and testing history. At minimum, that means a certificate of analysis (COA) tied to the lot number printed on the vial label, plus enough manufacturing metadata to confirm the two match. Without that pairing, a vial is essentially anonymous, and any purity or identity claim printed on a listing page is unverifiable.
Why Lot-Level Documentation Matters
Peptide synthesis happens in discrete batches, and no two batches are chemically identical even when they come from the same supplier and process. Purity, residual solvent levels, and peptide content can vary slightly from run to run. A certificate of analysis is only meaningful if it was generated from testing the same batch that produced the vial in hand — not a “representative” batch, and not a template document reused across multiple lots.
This is the core reason lot numbers exist as a system. The lot number on the vial label is the link between the physical product and its paper trail. If a listing shows a COA with no lot number, or a lot number that does not match the vial, the documentation is not doing its job, regardless of how professional the PDF looks.
Core Documents to Expect
A complete documentation package for a tesamorelin vial typically includes the following.
| Document | What It Confirms | Should Reference |
|---|---|---|
| Certificate of Analysis (COA) | Purity percentage, identity test result, peptide content | Matching lot number |
| HPLC report | Chromatographic purity, presence of related substances | Same lot as COA |
| Mass spectrometry data | Molecular weight confirms correct sequence/identity | Same lot as COA |
| Vial label | Lot number, net content, storage instructions | Matches COA header |
Not every supplier provides all four as separate files — HPLC and mass spec data are sometimes summarized within the COA itself rather than issued as standalone reports. What matters is that the identity and purity figures on the COA are traceable to actual instrument output for that lot, not asserted without supporting data.
Reading a Certificate of Analysis
A COA for a tesamorelin vial should show, at minimum: the lot number, a test date, the stated peptide content (usually expressed as a percentage of label claim or as net peptide content), an HPLC purity percentage, and an identity confirmation method such as mass spectrometry. Some certificates also list residual moisture, acetate content, or endotoxin testing results, depending on the supplier’s quality process.
The lot number is the field to check first. It should appear on both the COA and the physical vial label, and the two should match exactly — not be similar, not be from the same production week, but identical. A mismatch, even a single-digit one, breaks the chain between the paperwork and the product.
Batch Documentation and Reconstitution Records
Batch documentation describes what is in the vial before reconstitution. It does not track what happens after a buyer adds bacteriostatic water, and suppliers do not issue post-reconstitution certificates because reconstitution is not part of their manufacturing process. Any concentration math performed after reconstitution is the buyer’s own calculation, separate from the batch paperwork.
As a reference point for that calculation: a 10 mg vial reconstituted with 2 mL of bacteriostatic water yields a concentration of 5 mg/mL (10 mg ÷ 2 mL = 5 mg/mL). Converting to micrograms, that is 5000 mcg/mL (5 mg × 1000 mcg/mg). On a U-100 insulin syringe, where 1 mL equals 100 units, each unit drawn corresponds to 50 mcg (5000 mcg ÷ 100 units = 50 mcg per unit). These figures describe the arithmetic relationship between vial content and syringe markings; they are not a usage instruction, and buyers doing this math should verify it against the specific vial’s labeled content rather than assuming the example above applies to a different strength. A calculator such as peptcalc.com can cross-check the arithmetic for a given vial size and dilution volume.
Cross-Referencing Documentation Against a Listing
A listing that names a supplier and lot number is only as useful as the documentation backing it. Reference material comparing how supplier location and sourcing practices affect listing transparency and pricing structures is available across peer tesamorelin listing catalogs, which covers how documentation practices tend to differ across supplier regions. That kind of comparison is a useful companion to reading a single COA, since it puts one document in the context of broader industry norms rather than treating it in isolation.
When evaluating documentation attached to a specific product page, a useful cross-check is comparing the certificate against the product’s own reference listing, such as the tesamorelin page maintained by a given source, to see whether the lot-tracking format and testing scope described there matches what accompanies the vial.
Red Flags in Batch Paperwork
A few patterns indicate documentation that does not reliably represent the vial it accompanies:
- A COA with no lot number field, or a lot number that does not appear on the vial itself.
- A test date that is implausibly old relative to the product’s stated shelf life, or no test date at all.
- Purity or identity data presented as a screenshot or low-resolution image rather than a legible original document.
- The same COA file reused across multiple, differently dated listings.
- Missing identity confirmation (no mass spec or equivalent method), leaving only a purity percentage with nothing verifying the substance is tesamorelin at all.
Any one of these does not automatically mean the underlying product is mislabeled, but it does mean the documentation cannot be used to verify the claim it is attached to.
Summary
Batch documentation for a tesamorelin vial should include a certificate of analysis tied to a specific, matching lot number, supported by identity and purity data generated from testing that lot rather than a generic template. The lot number is the anchor connecting the physical vial to its paper trail, and any gap between the two — a missing lot number, a mismatch, or an undated report — undermines the documentation’s purpose regardless of how complete it otherwise appears.
A note on how to read this
This article is written for research and educational reference. The materials described are sold for laboratory research and are not for human consumption. Nothing here is dosing guidance, a prescription, or a clinical recommendation.